Keyphrases
Colorectal Cancer
100%
Pancreatic Cancer
92%
Pancreatic Ductal Adenocarcinoma
81%
Gastrointestinal Malignancies
81%
Tumor
74%
Exosomal
66%
Older Adults
65%
Geriatric Assessment
60%
Pancreatic Cancer Cells
56%
Gastrointestinal Cancer
52%
Exosomes
51%
Immune Checkpoint Inhibitors
50%
Resilience Assessment
47%
Aging Resilience
47%
Prognostic Significance
46%
CD63
44%
Frailty
40%
Adult Cancer
37%
Confidence Interval
37%
Genotype
36%
Gemcitabine
35%
Overall Survival
35%
Tumor Growth
35%
Tumor Metastasis
35%
Microsatellite Instability-high (MSI-H)
34%
Immunohistochemistry
33%
Pancreatic Adenocarcinoma
33%
Fluoropyrimidine
33%
Metastasis
30%
Honokiol
29%
Genomic Landscape
29%
Thyroid Hormone Receptor
29%
Hepatocellular Carcinoma
29%
Receptor-interacting Protein Kinase 1 (RIPK1)
29%
FOLFIRINOX
29%
Desmoplasia
29%
Molecular Differences
29%
Biliary Tract Cancer
29%
Tumor Protein p53 (TP53)
25%
Extracellular Vesicles
24%
Pancreatic Tumor
24%
Adjusted Odds Ratio
23%
Metastatic Colorectal Cancer (mCRC)
22%
Median Overall Survival
22%
Sonic Hedgehog
22%
1-year Mortality
22%
Programmed Death-ligand 1 (PD-L1)
21%
Cancer Types
20%
Chemoresistance
20%
Metastatic Pancreatic Ductal Adenocarcinoma
20%
Medicine and Dentistry
Pancreas Cancer
92%
Cancer
90%
Malignant Neoplasm
89%
Pancreas Adenocarcinoma
76%
Geriatric Assessment
60%
Overall Survival
58%
Metastatic Carcinoma
53%
Colorectal Carcinoma
50%
Neoplasm
48%
Frailty
46%
Gastrointestinal Cancer
42%
Chemoradiotherapy
36%
Immune Checkpoint Inhibitor
35%
Immunohistochemistry
35%
Microsatellite Instability
29%
Cancer Cell
29%
Biliary Tract Cancer
29%
Cancer Growth
24%
Tumor Mutational Burden
23%
Odds Ratio
23%
Pancreas Tumor
22%
Sonic Hedgehog Protein
22%
Epidermal Growth Factor Receptor
21%
Tumor Progression
20%
Frailty Index
20%
Progression Free Survival
18%
Catenin
18%
Cell Signaling Pathway
18%
Immunotherapy
18%
Functional Status
18%
Upregulation
17%
Cancer Types
17%
Drug Delivery System
17%
Hazard Ratio
17%
DNA Repair
16%
Fibroblast Growth Factor Receptor 2
16%
In Silico
16%
Desmoplasia
16%
Distant Metastasis
16%
Tumor Desmoplasia
16%
Stromal Tumor
16%
Immune Response
16%
Diseases
15%
Adrenomedullin
14%
Biliary Duct Cancer
14%
Erlotinib
14%
Strongyloidiasis
14%
Prostate Cancer
14%
Retrospective Cohort Study
14%
Magnetic Resonance Imaging
14%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
76%
Microsatellite Instability
48%
Immune Checkpoints
40%
Overall Survival
39%
Genomics
36%
Gene Mutation
35%
Gemcitabine
34%
Genotyping
34%
Upregulation
33%
Tumor Progression
31%
RNA
31%
Epidermal Growth Factor Receptor
30%
CD9
29%
CD63
29%
Prevalence
29%
KRAS
29%
DNA Mismatch Repair
27%
Immune Response
24%
ARID1A
23%
Drug Resistance
23%
Next Generation Sequencing
22%
Sonic Hedgehog
22%
RNA Sequence
20%
Wild Type
19%
Catenin
19%
Microsatellite
19%
Stellate Cell
19%
ATPase
18%
Carcinogenesis
18%
Drug Targeting
17%
Gene Signature
17%
Deep Sequencing
17%
Hedgehog Signaling Pathway
16%
Dihydropyrimidine Dehydrogenase
16%
STAT3
16%
Fibroblast Growth Factor Receptor 4
16%
DNA Repair
15%
Cell Communication
15%
Leucine Zipper
14%
Enzyme
14%
Erlotinib
14%
Gene Network
14%
POT1
14%
Membrane Transport
14%
Thyroid Hormone Receptor
14%
Epigenetics
14%
Digital Positive Youth Development
14%
Adrenomedullin
14%
Anus
14%
Transcriptomics
14%